List of Tables
    Table 1. Global Drugs for Anti-Infective Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Drugs for Anti-Infective Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Drugs for Anti-Infective Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Drugs for Anti-Infective Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Drugs for Anti-Infective Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Drugs for Anti-Infective Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Drugs for Anti-Infective Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Drugs for Anti-Infective Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Drugs for Anti-Infective Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Drugs for Anti-Infective Manufacturing Sites and Area Served
    Table 11. Manufacturers Drugs for Anti-Infective Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Drugs for Anti-Infective by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Anti-Infective as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Drugs for Anti-Infective Sales by Region (2017-2022) & (K Units)
    Table 16. Global Drugs for Anti-Infective Sales Market Share by Region (2017-2022)
    Table 17. Global Drugs for Anti-Infective Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Drugs for Anti-Infective Revenue Market Share by Region (2017-2022)
    Table 19. North America Drugs for Anti-Infective Sales by Country (2017-2022) & (K Units)
    Table 20. North America Drugs for Anti-Infective Sales Market Share by Country (2017-2022)
    Table 21. North America Drugs for Anti-Infective Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Drugs for Anti-Infective Revenue Market Share by Country (2017-2022)
    Table 23. Europe Drugs for Anti-Infective Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Drugs for Anti-Infective Sales Market Share by Country (2017-2022)
    Table 25. Europe Drugs for Anti-Infective Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Drugs for Anti-Infective Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Drugs for Anti-Infective Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Drugs for Anti-Infective Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Drugs for Anti-Infective Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Drugs for Anti-Infective Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Drugs for Anti-Infective Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Drugs for Anti-Infective Sales Market Share by Country (2017-2022)
    Table 33. Latin America Drugs for Anti-Infective Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Drugs for Anti-Infective Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Drugs for Anti-Infective Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Drugs for Anti-Infective Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Drugs for Anti-Infective Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Drugs for Anti-Infective Revenue Market Share by Country (2017-2022)
    Table 39. Global Drugs for Anti-Infective Sales by Type (2017-2022) & (K Units)
    Table 40. Global Drugs for Anti-Infective Sales Market Share by Type (2017-2022)
    Table 41. Global Drugs for Anti-Infective Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Drugs for Anti-Infective Revenue Share by Type (2017-2022)
    Table 43. Global Drugs for Anti-Infective Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Drugs for Anti-Infective Sales (K Units) by Application (2017-2022)
    Table 45. Global Drugs for Anti-Infective Sales Market Share by Application (2017-2022)
    Table 46. Global Drugs for Anti-Infective Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Drugs for Anti-Infective Revenue Share by Application (2017-2022)
    Table 48. Global Drugs for Anti-Infective Price by Application (2017-2022) & (USD/Unit)
    Table 49. GlaxoSmithKline Corporation Information
    Table 50. GlaxoSmithKline Description and Business Overview
    Table 51. GlaxoSmithKline Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. GlaxoSmithKline Drugs for Anti-Infective Product
    Table 53. GlaxoSmithKline Recent Developments/Updates
    Table 54. Merck Corporation Information
    Table 55. Merck Description and Business Overview
    Table 56. Merck Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Merck Drugs for Anti-Infective Product
    Table 58. Merck Recent Developments/Updates
    Table 59. Pfizer Corporation Information
    Table 60. Pfizer Description and Business Overview
    Table 61. Pfizer Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Pfizer Drugs for Anti-Infective Product
    Table 63. Pfizer Recent Developments/Updates
    Table 64. Novartis AG Corporation Information
    Table 65. Novartis AG Description and Business Overview
    Table 66. Novartis AG Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Novartis AG Drugs for Anti-Infective Product
    Table 68. Novartis AG Recent Developments/Updates
    Table 69. Gilead Sciences Corporation Information
    Table 70. Gilead Sciences Description and Business Overview
    Table 71. Gilead Sciences Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Gilead Sciences Drugs for Anti-Infective Product
    Table 73. Gilead Sciences Recent Developments/Updates
    Table 74. Abbott Corporation Information
    Table 75. Abbott Description and Business Overview
    Table 76. Abbott Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. Abbott Drugs for Anti-Infective Product
    Table 78. Abbott Recent Developments/Updates
    Table 79. Wyeth Corporation Information
    Table 80. Wyeth Description and Business Overview
    Table 81. Wyeth Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. Wyeth Drugs for Anti-Infective Product
    Table 83. Wyeth Recent Developments/Updates
    Table 84. Sanofi-Aventis Corporation Information
    Table 85. Sanofi-Aventis Description and Business Overview
    Table 86. Sanofi-Aventis Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. Sanofi-Aventis Drugs for Anti-Infective Product
    Table 88. Sanofi-Aventis Recent Developments/Updates
    Table 89. Bristol-Myers Squibb Corporation Information
    Table 90. Bristol-Myers Squibb Description and Business Overview
    Table 91. Bristol-Myers Squibb Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 92. Bristol-Myers Squibb Drugs for Anti-Infective Product
    Table 93. Bristol-Myers Squibb Recent Developments/Updates
    Table 94. Johnson Corporation Information
    Table 95. Johnson Description and Business Overview
    Table 96. Johnson Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 97. Johnson Drugs for Anti-Infective Product
    Table 98. Johnson Recent Developments/Updates
    Table 99. Roche Pharma AG Corporation Information
    Table 100. Roche Pharma AG Description and Business Overview
    Table 101. Roche Pharma AG Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 102. Roche Pharma AG Drugs for Anti-Infective Product
    Table 103. Roche Pharma AG Recent Developments/Updates
    Table 104. Nanosphere Corporation Information
    Table 105. Nanosphere Description and Business Overview
    Table 106. Nanosphere Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 107. Nanosphere Drugs for Anti-Infective Product
    Table 108. Nanosphere Recent Developments/Updates
    Table 109. NanoViricides Corporation Information
    Table 110. NanoViricides Description and Business Overview
    Table 111. NanoViricides Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. NanoViricides Drugs for Anti-Infective Product
    Table 113. NanoViricides Recent Developments/Updates
    Table 114. Novabay Pharmaceuticals Corporation Information
    Table 115. Novabay Pharmaceuticals Description and Business Overview
    Table 116. Novabay Pharmaceuticals Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. Novabay Pharmaceuticals Drugs for Anti-Infective Product
    Table 118. Novabay Pharmaceuticals Recent Developments/Updates
    Table 119. Obetech Corporation Information
    Table 120. Obetech Description and Business Overview
    Table 121. Obetech Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. Obetech Drugs for Anti-Infective Product
    Table 123. Obetech Recent Developments/Updates
    Table 124. Optimer Pharmaceuticals Corporation Information
    Table 125. Optimer Pharmaceuticals Description and Business Overview
    Table 126. Optimer Pharmaceuticals Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. Optimer Pharmaceuticals Drugs for Anti-Infective Product
    Table 128. Optimer Pharmaceuticals Recent Developments/Updates
    Table 129. Basilea Pharmaceutica AG Corporation Information
    Table 130. Basilea Pharmaceutica AG Description and Business Overview
    Table 131. Basilea Pharmaceutica AG Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 132. Basilea Pharmaceutica AG Drugs for Anti-Infective Product
    Table 133. Basilea Pharmaceutica AG Recent Developments/Updates
    Table 134. Daiichi Sankyo Corporation Information
    Table 135. Daiichi Sankyo Description and Business Overview
    Table 136. Daiichi Sankyo Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 137. Daiichi Sankyo Drugs for Anti-Infective Product
    Table 138. Daiichi Sankyo Recent Developments/Updates
    Table 139. MerLion Pharma Corporation Information
    Table 140. MerLion Pharma Description and Business Overview
    Table 141. MerLion Pharma Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 142. MerLion Pharma Drugs for Anti-Infective Product
    Table 143. MerLion Pharma Recent Developments/Updates
    Table 144. Theravance Corporation Information
    Table 145. Theravance Description and Business Overview
    Table 146. Theravance Drugs for Anti-Infective Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 147. Theravance Drugs for Anti-Infective Product
    Table 148. Theravance Recent Developments/Updates
    Table 149. Production Base and Market Concentration Rate of Raw Material
    Table 150. Key Suppliers of Raw Materials
    Table 151. Drugs for Anti-Infective Distributors List
    Table 152. Drugs for Anti-Infective Customers List
    Table 153. Drugs for Anti-Infective Market Trends
    Table 154. Drugs for Anti-Infective Market Drivers
    Table 155. Drugs for Anti-Infective Market Challenges
    Table 156. Drugs for Anti-Infective Market Restraints
    Table 157. Global Drugs for Anti-Infective Sales Forecast by Type (2023-2028) & (K Units)
    Table 158. Global Drugs for Anti-Infective Sales Market Share Forecast by Type (2023-2028)
    Table 159. Global Drugs for Anti-Infective Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 160. Global Drugs for Anti-Infective Revenue Market Share Forecast by Type (2023-2028)
    Table 161. Global Drugs for Anti-Infective Sales Forecast by Application (2023-2028) & (K Units)
    Table 162. Global Drugs for Anti-Infective Sales Market Share Forecast by Application (2023-2028)
    Table 163. Global Drugs for Anti-Infective Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 164. Global Drugs for Anti-Infective Revenue Market Share Forecast by Application (2023-2028)
    Table 165. Global Drugs for Anti-Infective Sales Forecast by Region (2023-2028) & (K Units)
    Table 166. Global Drugs for Anti-Infective Sales Market Share Forecast by Region (2023-2028)
    Table 167. Global Drugs for Anti-Infective Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 168. Global Drugs for Anti-Infective Revenue Market Share Forecast by Region (2023-2028)
    Table 169. Research Programs/Design for This Report
    Table 170. Key Data Information from Secondary Sources
    Table 171. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Drugs for Anti-Infective
    Figure 2. Global Drugs for Anti-Infective Market Share by Type in 2021 & 2028
    Figure 3. OTC Product Picture
    Figure 4. Rx Drugs Product Picture
    Figure 5. Global Drugs for Anti-Infective Market Share by Application in 2021 & 2028
    Figure 6. Hospital
    Figure 7. Drugs Store
    Figure 8. Other
    Figure 9. Global Drugs for Anti-Infective Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Drugs for Anti-Infective Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Drugs for Anti-Infective Sales (2017-2028) & (K Units)
    Figure 12. Drugs for Anti-Infective Sales Share by Manufacturers in 2021
    Figure 13. Global Drugs for Anti-Infective Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Drugs for Anti-Infective Players: Market Share by Revenue in 2021
    Figure 15. Drugs for Anti-Infective Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Drugs for Anti-Infective Sales Market Share by Region (2017-2022)
    Figure 17. Global Drugs for Anti-Infective Sales Market Share by Region in 2021
    Figure 18. Global Drugs for Anti-Infective Revenue Market Share by Region (2017-2022)
    Figure 19. Global Drugs for Anti-Infective Revenue Market Share by Region in 2021
    Figure 20. the United States Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. UK Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Taiwan Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Mexico Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Brazil Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Argentina Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Turkey Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Saudi Arabia Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. UAE Drugs for Anti-Infective Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Sales Market Share of Drugs for Anti-Infective by Type (2017-2022)
    Figure 43. Manufacturing Cost Structure of Drugs for Anti-Infective
    Figure 44. Manufacturing Process Analysis of Drugs for Anti-Infective
    Figure 45. Drugs for Anti-Infective Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed